We identified mitochondrial apoptotic signalling as a relevant mechanism responsible for chemo-resistance induced by the reduced expression of NR3C1 in ALL cells, and showed that this can be pharmacologically treated by Bcl-2 blockage. The gene discussed is BCL2; the disease is acute lymphoblastic leukemia.